Mobilization of hematopoietic progenitor cells with a combination of docetaxel, adriamycin, 5-fluorouracil and filgrastim in breast cancer patients
Pérez-Calvo, J.; Fernández-Hidalgo, O.; Subirá, M.L.; Martín-Algarra, S.; Salgado, E.; Brugarolas, A.
Haematologica 86(1): 100-101
2001
ISSN/ISBN: 0390-6078 PMID: 11146579 Document Number: 529149
Document emailed within 1 workday
Related Documents
Repetto, L.; Vannozzi, M.O.; Balleari, E.; Venturino, A.; Granetto, C.; Bason, C.; Simoni, C.; Prencipe, E.; Queirolo, P.; Esposito, M.; Ghio, R.; Rosso, R. 1999: Mitoxantrone in elderly patients with advanced breast cancer: pharmacokinetics, marrow and peripheral hematopoietic progenitor cells Anticancer Research 19(1b): 879-884Abe, O.; Izuo, M.; Enomoto, K.; Kubo, K.; Koyama, H.; Sakai, K.; Terasawa, T.; Tominaga, T.; Nomura, Y. 1982: Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 866-873
Chao, N.J. 1995: Mobilization of peripheral blood progenitor cells by hematopoietic growth factors Canadian Journal of Oncology 5(Suppl 1): 43-46
Ghielmini, M.; Tobler, A. 1996: Mobilization and transplantation of autologous hematopoietic stem and progenitor cells from peripheral blood: principles and applications Schweizerische Medizinische Wochenschrift 126(9): 348-356
Doihara, H.; Yoshitomi, S.; Hino, M.; Teramoto, A.; Ishibe, Y.; Ogasawara, Y.; Nagahiro, I.; Sano, Y.; Shimizu, N. 2001: Two cases of advanced and metastatic breast cancers treated by docetaxel in combination with intra-arterial infusion of adriamycin Gan to Kagaku Ryoho. Cancer and ChemoTherapy 28(2): 229-233
Slee, P.H.T.J.; Rodenburg, C.J.; Nortier, J.W.R.; van Bochove, A. 2004: A phase i dose-escalating study of docetaxel plus folinic acid and 5-fluorouracil in anthracycline-pretreated patients with metastatic breast cancer Netherlands Journal of Medicine 62(9): 314-319
Grimaz, S.; Damiani, D.; Michieli, M.; Baccarani, M. 2000: Mobilization of peripheral blood progenitor cells with G-CSF alone in lymphoma patients: steady-state circulating progenitor cell count predicts the autograft yield Haematologica 85(1): 102-103
Johnson, K.R.; Fan, W. 2002: Reduced expression of p53 and p21WAF1/CIP1 sensitizes human breast cancer cells to paclitaxel and its combination with 5-fluorouracil Anticancer Research 22(6a): 3197-3204
Ozeki, H.; Ogawa, M.; Horikoshi, N.; Inoue, K.; Mukaiyama, T.; Nagamine, D.; Ito, Y.; Imajo, K.; Shinagawa, K. 1988: Combination chemotherapy of 5-fluorouracil (5-FU), adriamycin (ADM), cis-diamminedichloroplatinum (II) (CDDP) and mitomycin C (MMC) (FAP.MMC) in advanced gastric cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(1): 91-95
Drize, N.; Chertkov, J.; Zander, A. 1995: Hematopoietic progenitor cell mobilization into the peripheral blood of mice using a combination of recombinant rat stem cell factor (rrSCF) and recombinant human granulocyte colony-stimulating factor (rhG-CSF) Experimental Hematology 23(11): 1180-1186
Grieco, A.; Lasorella, A.; Astone, A.; Vagliviello, L.; Bartoloni, C.; Barone, C. 1984: Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). a non-controlled study La Clinica Terapeutica 110(4): 353-358
Matsutani, T.; Sasajima, K.; Kobayashi, Y.; Suzuki, S.; Maruyama, H.; Miyamoto, M.; Yokoyama, T.; Sugiura, A.; Matsushita, A.; Yanagi, K.; Matsuda, A.; Arai, H.; Nishi, Y.; Wakabayashi, H.; Tajiri, T. 2009: A case of double advanced cancer with esophageal and hypopharyngeal carcinoma responding completely to combination chemotherapy of docetaxel/5-fluorouracil and nedaplatin with radiation Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(5): 835-838
Taguchi, T.; Sakai, K.; Terasawa, T.; Wada, H. 1986: Results of clinical trials with a CMitF (cyclophosphamide, mitoxantrone, and 5-fluorouracil) regimen versus a CAF (cyclophosphamide, adriamycin, and 5-fluorouracil) regimen in advanced/relapsed breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(9): 2820-2828
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504
Hortobágyi, G. 1997: Docetaxel in breast cancer and a rationale for combination therapy Oncology 11(6 Suppl 6: 11-15
Aapro, M.S. 1997: Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer Oncology 11(8 Suppl 8: 46-49
Yasuda, T.; Kabuto, T.; Ishiguro, S.; Nakano, H.; Nakamori, S.; Ohigashi, H.; Hiratsuka, M.; Kameyama, M.; Sasaki, Y.; Ishikawa, O. 1995: Preoperative neoadjuvant chemotherapy with a combination of 5-fluorouracil, adriamycin and cisplatin (FAP) for advanced esophageal cancer invading trachea or main bronchus Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(11): 1538-1541
Diéras, V. 1997: Review of docetaxel/doxorubicin combination in metastatic breast cancer Oncology 11(8 Suppl. 8): 31-33
Sulkes, A.; Uziely, B.; Isacson, R.; Brufman, G.; Biran, S. 1988: Combination chemotherapy in metastatic tumors of unknown origin. 5-Fluorouracil, adriamycin and mitomycin C for adenocarcinomas and adriamycin, vinblastine and mitomycin C for anaplastic carcinomas Israel Journal of Medical Sciences 24(9-10): 604-610
Dank, M.; Zergenyi, E.; Domotori, Z.S.; Lahm, E.; Kulka, J. 2003: Primary systemic therapy (PST) of locally advanced breast cancer using Doxorubicin/Docetaxel combination Anticancer Research 23(3c): 2879-2880